programmed celdeath
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
2 Years to 11 Years
Inclusion criteria
Inclusion criteria: age 2-24 months patient of: Emma Children's Hospital (outpatient clinic / ward)
Exclusion criteria
Exclusion criteria: History of pulmonary disorder No permission of caretakers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evidence for apoptosis: caspase-3 activity, annexin-V binding and morphological studies. Apoptotic pathways: RNA of the Bcl-2 and IAP family of pro- and anti-apoptotic factors, RNA and protein analysis of Fas/FasL and caspase-8 and -9 activity. | — |
Secondary
| Measure | Time frame |
|---|---|
| n.a. | — |
Countries
Netherlands
Outcome results
None listed